Question 1

How do I set a price alert for HCAT?

Accepted Answer

To set a HCAT price alert on Stock Alarm Pro, navigate to the HCAT quote page, select "Set Alert," choose your trigger type (price target, % move, RSI level, MACD, or volume breakout), and set your delivery channel. Stock Alarm Pro supports instant push notifications, SMS, and automated phone call alerts.

Question 2

Can I get phone call alerts for HCAT?

Accepted Answer

Yes. Stock Alarm Pro provides real-time automated phone call alerts for HCAT. Phone call alerts ensure you are immediately awakened or interrupted during critical volatility events, overnight earnings moves, or strict stop-loss levels when silent push notifications might be overlooked.

Question 3

What types of alerts can I set for Health Catalyst Inc?

Accepted Answer

Stock Alarm Pro supports over 125 trigger types for HCAT: price target alerts (above/below target), intraday percentage moves, RSI overbought/oversold levels, 50-day and 200-day moving average crossovers (golden cross / death cross), relative volume (RVOL) spikes, confirmed earnings date releases, and SEC Form-4 insider transaction filings.

Question 4

How quickly will I be notified about HCAT price changes?

Accepted Answer

HCAT alerts are evaluated continuously in real-time against live market telemetry. Notifications are dispatched within sub-second latency via push notifications, SMS, or phone calls as soon as your trigger condition is met across regular, pre-market, and after-hours trading sessions.

Question 5

Is Stock Alarm Pro free to use for HCAT alerts?

Accepted Answer

Yes, Stock Alarm Pro offers a free tier that includes 3 active price alerts for HCAT and other stocks. Full Pro membership is $20/month or $168/year with a 7-day free trial, unlocking unlimited alerts, phone call delivery, SMS, all 125+ technical indicators, institutional screeners, and real-time market telemetry across web, iOS, and Android.

Reported	EPS est	EPS actual	Surprise	Revenue est	Revenue actual	Surprise
Aug 6 2026	$0.03	$0.04	+33.9%	$69M	$70M	+2.0%
May 11 2026	$0.01	$0.02	+100.0%	$69M	$71M	+2.2%
Mar 12 2026	$0.09	$0.08	-11.1%	$74M	$75M	+1.0%
Nov 10 2025	$0.05	$0.06	+20.0%	$74M	$76M	+3.0%
Aug 7 2025	$0.03	$0.04	+33.3%	$85M	$81M	-5.2%
May 7 2025	$0.01	$0.01	+0.0%	$79M	$79M	+0.3%
Feb 26 2025	$0.11	$0.04	-63.6%	$80M	$80M	+0.0%
Nov 6 2024	$0.10	$0.07	-30.0%	$81M	$76M	-5.4%
Aug 7 2024	$0.09	$0.12	+33.3%	$75M	$76M	+1.2%
May 9 2024	$0.03	$0.05	+79.0%	$75M	$75M	-0.1%
Feb 22 2024	$0.00	$0.02	+2716.9%	$74M	$75M	+2.0%
Nov 2 2023	($0.03)	$0.03	+200.0%	$73M	$74M	+1.0%

Metric	FY2026E	FY2027E	FY2028E
Revenue Avg	$248M	$206M	$228M
Low	$248M	$201M	$223M
High	$248M	$210M	$234M
EBITDA Avg	$54M	$56M	$57M
Low	$54M	$41M	$56M
High	$54M	$59M	$57M
EBIT Avg	$11M	$20M	$25M
Low	$11M	$5M	$25M
High	$11M	$23M	$25M
Net Income Avg	$-3M	$5M	$9M
Low	$-3M	$-9M	$9M
High	$-2M	$8M	$9M
EPS Avg	$-0.04	$0.01	$0.13
Low	$-0.04	$-0.13	$0.13
High	$-0.04	$0.11	$0.13
Analysts (Rev / EPS)	4 / 3	4 / 3	1 / 1

Metric	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028	Q3 2028
Revenue Avg	$51M	$51M	$52M	$53M	$53M	$56M	$57M	$58M
Low	$51M	$50M	$51M	$52M	$52M	$55M	$56M	$57M
High	$51M	$52M	$53M	$54M	$54M	$57M	$58M	$59M
EBITDA Avg	$12M	$16M	$16M	$15M	$16M	—	—	—
Low	$12M	$16M	$16M	$15M	$16M	—	—	—
High	$12M	$16M	$16M	$15M	$16M	—	—	—
EBIT Avg	$2M	$6M	$6M	$6M	$7M	—	—	—
Low	$2M	$6M	$6M	$6M	$7M	—	—	—
High	$2M	$6M	$6M	$6M	$7M	—	—	—
Net Income Avg	$-3M	$1M	$1M	$739,600	$2M	—	—	—
Low	$-3M	$1M	$1M	$727,153	$2M	—	—	—
High	$-3M	$1M	$1M	$761,498	$2M	—	—	—
EPS Avg	$-0.04	$0.01	$0.01	$0.01	$0.03	—	—	—
Low	$-0.04	$0.01	$0.01	$0.01	$0.02	—	—	—
High	$-0.04	$0.02	$0.02	$0.01	$0.03	—	—	—
Analysts (Rev / EPS)	3 / 2	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Metric	FY2026E	FY2027E	FY2028E
Revenue Avg	$248M	$206M	$228M
Low	$248M	$201M	$223M
High	$248M	$210M	$234M
EBITDA Avg	$54M	$56M	$57M
Low	$54M	$41M	$56M
High	$54M	$59M	$57M
EBIT Avg	$11M	$20M	$25M
Low	$11M	$5M	$25M
High	$11M	$23M	$25M
Net Income Avg	$-3M	$5M	$9M
Low	$-3M	$-9M	$9M
High	$-2M	$8M	$9M
EPS Avg	$-0.04	$0.01	$0.13
Low	$-0.04	$-0.13	$0.13
High	$-0.04	$0.11	$0.13
Analysts (Rev / EPS)	4 / 3	4 / 3	1 / 1

Metric	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028	Q3 2028
Revenue Avg	$51M	$51M	$52M	$53M	$53M	$56M	$57M	$58M
Low	$51M	$50M	$51M	$52M	$52M	$55M	$56M	$57M
High	$51M	$52M	$53M	$54M	$54M	$57M	$58M	$59M
EBITDA Avg	$12M	$16M	$16M	$15M	$16M	—	—	—
Low	$12M	$16M	$16M	$15M	$16M	—	—	—
High	$12M	$16M	$16M	$15M	$16M	—	—	—
EBIT Avg	$2M	$6M	$6M	$6M	$7M	—	—	—
Low	$2M	$6M	$6M	$6M	$7M	—	—	—
High	$2M	$6M	$6M	$6M	$7M	—	—	—
Net Income Avg	$-3M	$1M	$1M	$739,600	$2M	—	—	—
Low	$-3M	$1M	$1M	$727,153	$2M	—	—	—
High	$-3M	$1M	$1M	$761,498	$2M	—	—	—
EPS Avg	$-0.04	$0.01	$0.01	$0.01	$0.03	—	—	—
Low	$-0.04	$0.01	$0.01	$0.01	$0.02	—	—	—
High	$-0.04	$0.02	$0.02	$0.01	$0.03	—	—	—
Analysts (Rev / EPS)	3 / 2	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

EPS surprise

Earnings & Revenue Estimates

Explore More